Opinion: Taking the Pulse of Horizon Europe

The plan to revitalize the European innovation landscape is entering a transition.

Written byMarc Baiget Francesch
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, VJANEZ

With the arrival of 2020, the decade of the 2010s has come to an end, and with it the most ambitious European research and innovation funding program enters its final year. Horizon 2020, the European Union (EU) seven-year plan kickstarted in 2014, is making way for Horizon Europe. This successor program will cover the EU research and innovation strategy between 2021 and 2027, and is poised for transition after a provisional agreement was reached last April between the Council of the EU and the colegislators.

But within this provisional agreement, the final budget—which the European commission proposed to be around €100 billion (more than $111 billion US), a sizeable increase from the €80 billion (more than $89 billion US) that was previously budgeted for Horizon 2020 and about 1.3 percent of the EU total budget—is still not clear. If Horizon Europe’s budget is finalized in this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery